The prostate gland of humans and many other animals has the major function of accumulating and secreting extraordinarily high levels of citrate. This specialized metabolic process of ''net citrate production'' is the result of unique metabolic capabilities of the secretory epithelial cells. Most imp
Citrate transport and metabolism in mammalian cells : Prostate epithelial cells and prostate cancer
โ Scribed by Maria E. Mycielska; Ameet Patel; Nahit Rizaner; Maciej P. Mazurek; Hector Keun; Anup Patel; Vadivel Ganapathy; Mustafa B. A. Djamgoz
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 348 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0265-9247
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The prostate gland of many animals accumulates extremely high levels of zinc and citrate. Evidence currently exists in support of a concept that zinc might be an important regulator of m-aconitase and citrate oxidation of prostate epithelial cells. No information concerning the mitochondrial levels
## Background: One of the major current problems involved in prostate cancer (pca) is the unavailability of sensitive, accurate, and preferably noninvasive procedures for the diagnosis of pca. moreover, procedures are needed which will permit the early detection, staging, location, and estimation o
Changes in cell-cell interactions are critical in the process of cancer progression. Likewise, it has been shown that loss of expression of the cell adhesion molecule E-cadherin is associated with grade, stage, and prognosis in many carcinomas, including prostate cancer. Impaired E-cadherin-mediated
Two prostatic epithelial lines, one of basal origin and one of luminal origin, were established from the dorsolateral prostates of p53 null mice. The cell lines are nontumorigenic when inoculated subcutaneously under the renal capsule or intraprostatically in syngeneic mice. The luminal cell line (P
Gain of sequences on chromosome arm 8q is a common feature of prostate cancer that may correlate with metastatic and androgen-independent progression. The target gene(s) for this gain is not known, although MYC is amplified in a subset of advanced tumors and is one potential candidate. Prostate stem